FDA grants avatrombopag Orphan Drug Designation for the treatment of Chemotherapy-Induced Thrombocytopenia
- 09 January 2020 |
ITP in the News
ASH Releases New Clinical Practice Guidelines on Immune Thrombocytopenia
- 04 December 2019 |
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
- 27 November 2019 |
Nawaz Sharif remains critical, platelet count drops again
- 04 November 2019 |
New hope for ITP patients dashed by high drug cost in Canada
- 25 October 2019 |
Pakistan's ex-Prime Minister Sharif diagnosed with immune disorder
- 25 October 2019 |
Nplate® (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
- 21 October 2019 |
Rigel Receives Positive Trend Vote from CHMP for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe
- 21 October 2019 |
Principia Announces Positive Preliminary Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
- 16 October 2019 |
Wheeler's Nowak plays four sports despite blood disorder
- 09 October 2019 |
Clinical trial tests novel treatment strategy for ITP
- 09 October 2019 |
He's all smiles: Serious disorder can't deter St. Peter's soccer player
- 09 September 2019 |
Information About Immune Globulin (Human) Product Shortage
- 21 August 2019 |
IG Manufacturer Toll-Free Numbers
- 31 July 2019 |
NORD’s 2019 Living Rare, Living Stronger Weekend
- 28 June 2019 |
FDA approves Doptelet for chronic immune thrombocytopenia
- 27 June 2019 |
12-year-old with ITP Invents 'Medi Teddy' IV
- 25 June 2019 |
ITP Patient Alexa Udom Excels at State Golf Tournament
- 17 May 2019 |
Novartis issues voluntary nationwide recall of Promacta ® 12.5 mg for oral suspension due to potential peanut contamination
- 12 May 2019 |
Rare blood disorder almost ended Boise State athlete’s career. It also inspired her.
- 20 April 2019 |
Chili cookoff for ITP
- 02 April 2019 |
PDSA Named Rare Disease Changemaker by the National Organization for Rare Disorders (NORD)
- 02 April 2019 |
Former NFL pro Jeff Chadwick and Kristen Blackburn host fundraisers for PDSA in Michigan
- 16 February 2019 |
Kids Wish Network sending Beloit family to Disney and Universal
- 11 February 2019 |
We Live Day by Day
- 06 February 2019 |
Komets rallying around athletic trainer’s daughter
- 18 January 2019 |
Romiplostim Elicits High Responses in Pediatric Immune Thrombocytopenia
- 21 December 2018 |
Clinical Challenges: Pediatric ITP
- 10 December 2018 |
Caroline Kruse Named President and CEO of the Platelet Disorder Support Association
- 22 October 2018 |
Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura
- 19 October 2018 |
How patients are helping drive research and drug development
- 17 October 2018 |
Texas Children’s hematologists contribute to leading textbook in field
- 12 October 2018 |
Five-year-old Wrexham boy with unusual and rare disease takes part in photo project to raise awareness
- 04 October 2018 |
Sara's story: A blessing in disguise
- 02 October 2018 |
Paying Attention to the signals: 23-year-old SCV resident searching for liver-transplant donor
- 24 September 2018 |
Sanofi’s Cablivi cleared for rare bleeding disorder (TTP)
- 10 September 2018 |
How can I increase my platelet count naturally?
- 10 September 2018 |
Retired teacher and 10-year-old girl form special bond during medical treatments
- 04 September 2018 |
Novartis’ severe aplastic anaemia drug fast-tracked by FDA
- 04 June 2018 |
Allegheny County settles with parents improperly accused of child abuse
- 07 February 2018 |
Former ‘Tenors’ Singer Remigio Pereira Reveals Health Scare, Shares Update With Fans
- 08 October 2017 |
Red Deer’s Canadian Blood Services saves lives
- 26 September 2017 |
Cayden, ITP patient, recognized at Green Bay Packers' game
- 22 September 2017 |
Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience
- 22 September 2017 |
argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in immune thrombocytopenia
- 22 September 2017 |
Novartis’ Revolade proved effective for seniors
- 11 September 2017 |
Protalex Doses First Patient in Third Cohort of European Phase 1b Study of PRTX-100 in ITP
- 05 September 2017 |
Role of Polymorphisms in Idiopathic Thrombocytopenic Purpura: A Review
- 05 September 2017 |
Quick Consult: Symptom: Arm and Back Rash
- 05 September 2017 |
Mum’s heartbreak at having to ban her five-year-old daughter from playing with her friends
- 21 August 2017 |
Protalex Completes Data Analysis of Second Dose Cohort of U.S. Phase 1/2 Study of PRTX-100 in ITP
- 02 August 2017 |
Oklahoma researchers zero in on cause of blood disorder
- 31 July 2017 |
FDA Accepts New Drug Application for Chronic ITP Treatment
- 22 June 2017 |
Weill Cornell team creates breakthrough on blood disorders
- 10 June 2017 |
Bishop Sutton student's warrior spirit
- 16 May 2017 |
